| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/13/2007 | US7176236 Water-soluble etoposide analogs and methods of use thereof |
| 02/13/2007 | US7176235 10,11-Dehydroepothilones; anticancer, antiproliferative and antiarthritic agents |
| 02/13/2007 | US7176234 Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosis |
| 02/13/2007 | US7176233 Salinosporamides and methods for use thereof |
| 02/13/2007 | US7176232 Fermentation product of marine actinomyces strains; antiproliferative agents; anticancer agents |
| 02/13/2007 | US7176231 For example, 5-acetyl-3-{[4-(diethylaminomethyl)-phenylamino]-phenyl-methylidene}-2-indolinone; for treatment of diabetes mellitus, diabetes associated disorders such as diabetic neuropathy, degenerative neurological diseases such as Alzheimer's disease, stroke, neurotraumatic injuries, bipolar disorders |
| 02/13/2007 | US7176230 For example, N-benzenesulfonyl-3-(5'-hydroxymethyl-2'-furyl)indole; anticoagulants, vasodilators |
| 02/13/2007 | US7176229 Pyrrolidine antiinflammatory agents for rheumatoid arthritis, osteoarthritis; antiallergens for asthma, chronic bronchitis, allergic rhinitis, adult respiratory distress syndrome, chronic pulmonary inflammatory disease; reduce or eliminate adverse CNS side effects associated with prior PDE4 inhibitors |
| 02/13/2007 | US7176228 Amidobiphenyloxime derivatives, useful as fungicide or bactericide for protection of crops and materials |
| 02/13/2007 | US7176225 For example, (6aR,7aS,8S,11aS)-5,8-bis(dimethylamino)-2-(2,2-diphenylvinyl)-9,11a,12-trihydroxy-11,13-dioxo-6,6a,7,7a,8,11,11a,13-octahydrotetraceno[2,1-d][1,3]oxazole-10-carboxamide; useful against antibiotic resistant organisms |
| 02/13/2007 | US7176224 Oxazolyl-aryloxyacetic acid derivatives and their use as PPAR agonists |
| 02/13/2007 | US7176223 5-(3-Pyridylmethyl)imidazolidine-2,4-dione is subjected to a hydrolysis reaction, wherein the reaction is followed by a decarbamation reaction to obtain (3-pyridyl)alanine |
| 02/13/2007 | US7176222 Contacting a base with an enantiomerically pure hydroxyl group containing compound, reacting the product with a nitro, fluoro-containing benzene compound, reducing the product to the corresponding amine |
| 02/13/2007 | US7176221 Low dose pharmaceutical composition having uniform drug distribution and potency |
| 02/13/2007 | US7176220 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
| 02/13/2007 | US7176219 Salts of quinuclidine derivative |
| 02/13/2007 | US7176218 Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders |
| 02/13/2007 | US7176217 such as N-Hydroxy-2-[(4-methoxyphenyl)sulfonyl]-2-azabicyclo[2.2.1]heptane-3-carboxamide, used in cosmetics or drugs as gelatinase inhibitors, for preventing skin aging or wrinkling; preventing diseases due to abnormal metabolism of tissue matrices such as arthritis, ulcers, metastasis or tumors |
| 02/13/2007 | US7176216 Antagonist for corticotropin-releasing factor receptors |
| 02/13/2007 | US7176215 Bicyclic oxopyridine and oxopyrimidine derivatives |
| 02/13/2007 | US7176214 Imidazo-fused oxazolo[4,5-β]pyridine and imidazo-fused thiazolo[4,5-β]pyridine based tricyclic compounds and pharmaceutical compositions comprising same |
| 02/13/2007 | US7176213 For example, 1-(9-benzylamino-10-cyano-imidazo[1,2-a]quinolin-2-carbonyl)pyrrolidine; may be used for the treatment of diseases such as asthma, glaucoma, tumors, allergic and inflammatory diseases, ischemia, hypoxia, arrythmia and renal diseases |
| 02/13/2007 | US7176212 2,4-diamino pyrimidine compounds having anti-cell proliferative activity |
| 02/13/2007 | US7176211 For example, 3-[2(R)-{hydroxycarbonylpropyl-amino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methyl-pyrimidine-2,4(1H,3H)-dione; use in treating prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
| 02/13/2007 | US7176210 Cannabinoid receptor ligands and uses thereof |
| 02/13/2007 | US7176208 Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors |
| 02/13/2007 | US7176207 Anticoagulants; antithrombotic agents in the treatment and prevention of thrombosis |
| 02/13/2007 | US7176206 Antibiotics |
| 02/13/2007 | US7176205 Bi-pyridinyl derivatives as NK-1 antagonists |
| 02/13/2007 | US7176204 Substituted carboxylic acid derivatives |
| 02/13/2007 | US7176203 Imidazo-triazine derivatives as ligands for gaba receptors |
| 02/13/2007 | US7176202 Such as 2-chloro-N-(1-hydroxy-cycloheptylmethyl)-5-[4-(2-hydroxy-3-methoxy-propyl)-3,5-dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl]-benzamide; purinergic receptors (P2x7 E); for treatment of interleukin-1 associated disorders, rheumatoid arthritis |
| 02/13/2007 | US7176201 Modulation of anxiety through blockade of anandamide hydrolysis |
| 02/13/2007 | US7176200 Derivatives of sulphonamides, their preparation and use as medicaments |
| 02/13/2007 | US7176199 Useful as a preventive or/and a therapeutic agent for a disease in which alpha v beta 3 integrin is involved |
| 02/13/2007 | US7176198 1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of disease |
| 02/13/2007 | US7176197 Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid |
| 02/13/2007 | US7176196 Bicyclic heterocycles as HIV integrase inhibitors |
| 02/13/2007 | US7176195 Treatment of nocturnal enuresis, nocturia, polyuria resulting from central diabetes insipidus, urinary incontinence or bleeding disorders such a hemophilia |
| 02/13/2007 | US7176194 Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use |
| 02/13/2007 | US7176193 Antilipemic agents; therapy for insulin resistance |
| 02/13/2007 | US7176192 Method for treating patients for radiation exposure |
| 02/13/2007 | US7176191 Bi phosphate containing protonated compound with two end groups; disinfecting surfaces of surgical equipments and skin |
| 02/13/2007 | US7176190 Comprises transgenic potato which generates starch with modified viscosity and phosphate characteristics; for enhancing quality of paper, cardboard, adhesive, textile, plaster, concrete, fertilizer, medicine and toothpaste; improving animal feeds |
| 02/13/2007 | US7176189 Methods for regeneration of a mammalian lens |
| 02/13/2007 | US7176188 Method of lethally sensitizing human and animal cells |
| 02/13/2007 | US7176187 Fusion proteins based upon somatostatin receptors |
| 02/13/2007 | US7176181 Enhancement or inhibition of the interactions of galectin-8 and galectin-8-like proteins with other extracellular matrix proteins or cell surface receptors; the use of modulators of cell adhesion; antitumor, -carcinogenic, -metastasis agents |
| 02/13/2007 | US7176180 Fusion proteins; immunoglobulins; kits |
| 02/13/2007 | US7176178 Protein H and its fragments/derivatives are capable of interacting with nucleophosmin/B23, actin, NPM/B23, protein SET or hnRNP A2/B1 |
| 02/13/2007 | US7176164 1,3-selenazolin derivatives and process for preparing the same |
| 02/13/2007 | US7176163 Pharmacological effect potentiators for pesticides |
| 02/13/2007 | US7175994 Lactacystin, a peptidyl aldehyde, or a peptidyl epoxy ketone inhibits proteasomal activity; epidermal growth factor, a fibroblast growth factor, a platelet-derived growth factor, a transforming growth factor, a parathyroid hormone, etc for promoting skin tissue growth, an excipient |
| 02/13/2007 | US7175987 administering to mammals mixtures of plant extracts from ginger, green tea, turmeric, horseradish and carriers |
| 02/13/2007 | US7175859 aqueous extract of stems or leaves or stems and leaves of one or more Cissus quandragularis plants to promote weight loss; combined with chitosan and amylase inhibitor |
| 02/13/2007 | US7175858 flowable composition that sets into a solid calcium phosphate containing product; for the repair of hard tissue defects, e.g., bone defects |
| 02/13/2007 | US7175856 Mixing drug with arginine; reduction of bitter taste |
| 02/13/2007 | US7175855 Ziprasidone suspension |
| 02/13/2007 | US7175854 Pharmaceutical preparation comprising an active dispersed on a matrix |
| 02/13/2007 | US7175853 Therapeutic system which can be moisture-activated |
| 02/13/2007 | US7175850 Formulation for topical non-invasive application in vivo |
| 02/13/2007 | US7175844 Administering an agent that inhibits a component of the VEGF signal transduction pathway; agent decreases a connective tissue growth factor (CTGF) activity in the tissue of the subject. |
| 02/13/2007 | US7175840 Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof |
| 02/13/2007 | US7175837 Stimulation of said skin's stratum corneum turnover rate; also contains surfactant(s) and a chelating agent |
| 02/13/2007 | US7175836 Cosmetics can be formulated to manipulate light transmission; for enhancing facial radiance; water-in-oil emulsifying silicone surfactant; crosslinked silicone elastomer; and a conjugated linoleic acid |
| 02/13/2007 | US7175835 stabilized against color and viscosity degradation; protect exposed skin against sunburn, cancer and even photoaging |
| 02/13/2007 | US7175658 Coated with fibronectin on the interior surface, and having endothelial cells genetically altered to express a full-length human fibulin-5 polypeptide seeded and cultured on the interior surface of the tubular element; better adhesion of cells to the graft |
| 02/13/2007 | CA2463976C N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase |
| 02/13/2007 | CA2387198C Method for treating hair loss using thyromimetic compounds |
| 02/13/2007 | CA2361288C Mutual prodrug of amlodipine and atorvastatin |
| 02/13/2007 | CA2359744C Cephalosporins and homologues preparations and pharmaceutical compositions |
| 02/13/2007 | CA2359510C .omega.-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 02/13/2007 | CA2358840C Methods and kits comprising an estrogen agonist/antagonist for improving vascular health |
| 02/13/2007 | CA2295119C Use of a specific antagonist of 5ht2 receptors for preparing medicines useful for treating sleep-disordered breathing |
| 02/13/2007 | CA2285037C Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same |
| 02/13/2007 | CA2266378C Use of sibutramine analogues to lower lipid levels |
| 02/13/2007 | CA2254759C Inhibitors of prenyl transferases |
| 02/13/2007 | CA2233501C Application of nanoparticles based on hydrophilic polymers as pharmaceutical forms |
| 02/13/2007 | CA2220649C 4-hydroxy-piperidine derivatives |
| 02/13/2007 | CA2194399C Novel carbapenem derivative |
| 02/13/2007 | CA2123241C Nucleosides and oligonucleotides having 2'ether groups |
| 02/13/2007 | CA2122236C Quinolines and their analogs |
| 02/13/2007 | CA2084987C Nucleic acid ligands |
| 02/12/2007 | WO2008041966A2 Broad spectrum antibacterial compounds |
| 02/12/2007 | CA2617123A1 Broad spectrum antibacterial compounds |
| 02/12/2007 | CA2553115A1 Modulation of peroxisome proliferation-activated receptors |
| 02/09/2007 | CA2618974A1 Nanoemulsion compositions having anti-inflammatory activity |
| 02/08/2007 | WO2007016679A2 Combination immediate release controlled release levodopa and carbidopa dosage forms |
| 02/08/2007 | WO2007016677A2 Nitric oxide enhancing antimicrobial compounds, compositions and methods of use |
| 02/08/2007 | WO2007016676A1 Tizanidine compositions and methods of treatment using the compositions |
| 02/08/2007 | WO2007016674A2 2-aminoaryl pyridines as protein kinases inhibitors |
| 02/08/2007 | WO2007016656A2 Modulators of hypoxia inducible factor-1 and related uses for the treatment of ocular disorders |
| 02/08/2007 | WO2007016650A2 M3 muscarinic acetylcholine receptor antagonists |
| 02/08/2007 | WO2007016630A1 Sterol fortified beverages |
| 02/08/2007 | WO2007016610A2 Antibacterial agents |
| 02/08/2007 | WO2007016582A2 Amorphous aprepitant coprecipitates |
| 02/08/2007 | WO2007016578A2 Prenylflavonoid formulations |
| 02/08/2007 | WO2007016563A2 Alcohol resistant pharmaceutical formulations |
| 02/08/2007 | WO2007016538A2 Preparation and use of biphenyl amino acid derivatives for the treatment of obesity |
| 02/08/2007 | WO2007016532A2 Mutations and polymorphisms of hdac4 |